The effect of inhaled bromhexine on clinical symptoms and recovery of COVID-19
Phase 3
Recruiting
- Conditions
- Dyspnea.Abnormalities of breathing
- Registration Number
- IRCT20230514058188N1
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
Patients with COVID-19 confirmed by PCR
Patients with respiratory symptoms including caugh and dyspnea
Exclusion Criteria
Need to mechanical ventilation
Pregnancy or lactating
Peptic ulcer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cough Severity. Timepoint: Before intervention and daily up to 7 day after intervention. Method of measurement: Visual Analogue Score.
- Secondary Outcome Measures
Name Time Method Arterial blood O2 saturation. Timepoint: Before intervention and daily up to 7 days after intervention. Method of measurement: Atrial blood gas measurment.;Arterial blood carbon dioxide level. Timepoint: Before intervention and daily up to 7 days after intervention. Method of measurement: Atrial blood gas measurment.